Sharon Klahre | Head, Investor Relations |
Michael Metzger | Chief Executive Officer |
Briggs Morrison | President and Head, R&D |
Keith Goldan | Chief Financial Officer |
Anjali Ganguli | Chief Business Officer |
Phil Nadeau | Cowen & Company |
Kalpit Patel | B. Riley Securities |
Ashiq Mubarack | Citi |
Joel Beatty | Baird |
Peter Lawson | Barclays |
Good day everyone and welcome to the Syndax Second Quarter 2022 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Sharon Klahre Head of Investor Relations at Syndax Pharmaceuticals.
Great. Thank you operator.